InnoCare Pharma announced that 10 studies from InnoCare’s oncology pipeline were selected for presentation at the 65th American Society of Hematology Annual Meeting on December 9-12, 2023 in San Diego, California, United States.
InnoCare Pharma announced that 10 studies from InnoCare’s oncology pipeline were selected for presentation at the 65th American Society of Hematology Annual Meeting on December 9-12, 2023 in San Diego, California, United States.